Clene Inc. (CLNN) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Clene Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$4.03
+1.51% today
Market cap
$56M
Overall quality
50/100
Kronos AI 30-day
+17.3%
8 of 8 simulated paths end higher
Clene Inc. (CLNN) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $56M. It trades at $4.03, up 1.51% today. Its overall quality score is 50 out of 100, ranked against the whole US market. 4 analysts' average target of $27.75 implies +588.6% from today's price. Kronos AI's 30-day forecast is +17.3% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $27.75 |
| Low – high | $20.00 – $31.00 |
| Analysts | 4 |
| Upside to average | +588.6% |
Kronos AI 30-day forecast
| Expected close | $4.65 (+17.3%) |
| Likely range | +13.4% … +29.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 50 |
| Solvency | 33 |
| Growth | 66 |
| Overall | 50 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.